Difference between revisions of "Bovine Leukaemia Virus"
Line 69: | Line 69: | ||
=Treatment= | =Treatment= | ||
+ | None Available | ||
=Control= | =Control= |
Revision as of 14:23, 2 June 2011
²
Also Known As — Enzootic Bovine Leucosis — Bovine leukosis — EBL — BLV — Bovine leukemia — lymphosarcoma — Sporadic Bovine Leukosis — Bovine Malignant Lymphoma
Introduction
Bovine leukaemia virus is a retrovirus causing two specific diseases: Bovine lymphosarcom and Persistent lymphocytosis.
Bovine lymphosarcoma is fatal while persistent lymphocytosis is not usually so.
Bovine leukosis is not transmissible to humans.
This disease is notifiable to the World Organisation for Animal Health (OIE)
Signalment
Cattle are thought to be the only species naturally susceptible, and prevalence rates are higher in dairy breeds than beef. The majority of infected animals are more than 2 years of age, with younger animals developing sporadic bovine leukosis which is thought to be unrelated – see below.
Sheep are susceptible to experimental infection which appears more pathogenic in this species.
Manifestation of the fatal neoplastic lymphosarcoma form of disease also appears better represented in dairy cattle.
Sporadic bovine leucosis is seen in young animals and causes thymic and cutaneous lymphosarcome. These animals are usually seronegative for EBL and so the pathogenesis is thought to be different to enzootic bovine leukosis.
Distribution
BLV is globally distributed, but prevalence widely varies.
While 89% dairy operations in the USA showed seropositive results and 43.5% of all USA dairy cattle were seropositive [1], seroprevalence in the EU rarely exceeds 0.5-1.5%. [2]
Clinical Signs
Transmission
Transmission of bovine leukaemia virus is mainly horizontal. Iatrogenic procedures are an important route as they facilitate transfer of contaminated blood between individuals, e.g. vaccinations, dehorning, rectal examinations and surgical procedures. Natural transmission by direct contact requires contact with infected blood, exudates or tissues which enter through broken skin. Vertical transmission is most likely from colostrums/milk and is less important, although it does provide a method for control.
Lymphosarcoma
The most common presentation is that of enlarged lymph nodes which may cause multiple palpable swellings in the pharynx, flanks and limbs. This is often an early indicator of disease.
5-20% cases are peracute and present as sudden death. This is thought to be due to sequelae such as adrenal gland involvement or rupture of abomasal ulcers etc.
Other signs are multisystemic and non-specific:
Cardiovascular – Dysrhythmmias, jugular distension, tachycardia, murmurs
Gastrointestinal – Anorexia, hepatomegaly, dysphagia, constipation or diarrhoea, abomasal tympany, hypomotility
Retrobulbar tumours sometimes cause blindness and other ocular signs.
Neurological signs and lameness also sometimes occur due to local tumour growth.
Animals are usually afebrile.
Infected animals become permanent carriers.
Persistent Lymphocytosis
Persistent lymphocytosis is defined by an increase in total lymphocyte count by 3 times the normal standard deviation above normal, persisting for at least three months with no clinical signs of neoplastic lesions. This is thought to represent 1/3 of all BLV infected cattle.
Diagnosis
Identification of enlarged lymph nodes without a raised rectal temperature may instigate suspicion.
Agar Gel Immuno Diffusion (AGID) is the official standard test approved by most governments. This test is usually accurate by 2-4weeks following infection. This test however cannot differentiate between infected cattle and those with passive immunity from colostrum.
Radioimmunoassay and serum or bulk milk ELISA are also available. Antibodies may not be present for up to 12 weeks following onset of infection.
PCR can also be performed on peripheral blood lymphocytes.
Multiple, firm white tumours may be present in any organ on post-mortem examination. In young animals, the common sites are the kidneys, thymus, liver, spleen, and lymph nodes. In adults, the heart, abomasum, and spinal cord are often involved.
Treatment
None Available
Control
References
- ↑ USDA/APHIS/Veterinary Services, 1997. High prevalence of BLV in US dairy herds. Fort Collins, CO, USA: USDA: APHIS:VS Centers For Epidemiology and Animal Health.
- ↑ Lorenz, R. J., Straub, O. C. (1987) The epidemiology of enzootic bovine leukosis. In: Burny A, Mammerick, M, eds. Enzootic bovine leukosis and bovine leukemia virus. Boston, USA: Martinus Nijhoff Publishing, 51-68